Scalper1 News
Valeant Pharmaceuticals (VRX) and hedge fund Pershing Square early Tuesday officially announced an unsolicited takeover bid for Allergan (AGN) that values the Botox-maker at more than $47 billion. News of the pending deal broke late Monday, but in a Tuesday SEC filing, Valeant and Pershing said they are offering $48.30 in cash and 0.83 Valeant shares for each Allergan share. Valeant stock was up more than 5%, near 132.50, in midday trading in the Scalper1 News
Scalper1 News